Powerpoint

advertisement

Stepping Up: Nurses Role in MDR-

TB/HIV Co-Infection in South Africa

Primary Healthcare Nurse Practitioner

(PHC-NP) and Medical Officer (MO) Task

Sharing of MDR-TB in Rural Kwa-Zulu

Natal, South Africa

Jason Farley, PhD, MPH, NP, FAAN

Associate Professor, Johns Hopkins University School of Nursing

Adjunct Associate Professor, Uni. of KZN, SA and Uni. of Technology Sydney

Pres-Elect, Association of Nurses in AIDS Care www.aids2014.org

Co-Investigators

Farley, J.E.

1 ; Walshe, L.

1 ; Budhathoki, C.

1 ;

Mlandu, N.

2 ; Nomusa, N.; Ndjeka, N.

3 ; van der Walt, M.

4

Johns Hopkins University School of Nursing 1 ; Ugu District

Department of Health, KwaZulu Natal, South Africa 2 ;

South African National Department of Health 3 ; South

African Medical Research Council 4 www.aids2014.org

TB in South Africa

• South Africa has the 2 nd highest rate of new

TB cases in the world

(http://www.cdc.gov/tb/topic/globaltb/Southafrica.htm)

• Highest rate of drug-resistant TB cases in

Africa

(http://www.cdc.gov/tb/topic/globaltb/Southafrica.htm)

• 4 th Highest Prevalence of HIV/AIDS

(http://www.cdc.gov/tb/topic/globaltb/Southafrica.htm)

• Over 70% of all TB cases co-infected with HIV

(SA DOH, 2012) www.aids2014.org

Background

• Following national guidelines, every effort should be made to ensure eligible clients are enrolled as soon as possible.

– all primary care, antenatal,

TB and mobile outreach health facilities must become fully functional nurse-initiated

ART and MDR-TB initiation sites for adults, children and pregnant women.

www.aids2014.org

Methods

• Prospective cohort of MDR-TB patients jointly managed by a PHC-NP and a MO.

– Patients who initiated treatment between January 1 and December 31,

2012

– Who either completed IP or experienced a negative outcome (i.e., death, failure, default) were included.

• We evaluate the intensive phase (IP) quality indicators and risk for IP negative outcomes.

• Descriptive statistics by provider type for demographic and time-to-event variables. www.aids2014.org

Methods Cont’d

• Provider comparisons for time-to-event IP indicators were made using a log-rank test, and contribution of other covariates, e.g. gender, HIV status assessed.

• Cumulative risk of remaining event free beyond a time point shown using a Kaplan-Meier plot

• A competing risk analysis with death, failure or default as competing negative outcomes was completed. www.aids2014.org

PREPARATIONS OF CLINICAL

NURSE PRACTITIONER

www.aids2014.org

Diagnosis and Clinical Management of MDR-TB

Short Course Overview

Mentored Training Experiences:

 Audiology training

 Visual assessment training

 Laboratory Monitoring & Evaluation

 ADR evaluation & treatment www.aids2014.org

1 week intensive theory

+

1 Month CNP Clinical

Mentoring

+

Competency Evaluation

+

Ongoing Clinical Mentoring

Developing Systems Level Strategies for Safe

Prescribing www.aids2014.org

Original Assignment to Provider

• After extensive training of the PHC-NP, patients were assigned a primary provider with task sharing throughout.

CNP

Outpatient

Standardized

MDR-TB

Treatment per guidelines

Standardized HIV

Management

MD

Hospital

Patients requiring any changes to standardized treatment

Baseline liver disease, baseline renal disease, seizure, psychosis, pregnant, low BMI (<45 kg)

<13 years old, Diabetic, past Drug induced hepatitis, Re-treatment MDR-

TB, Requires O2 support; Nonambulatory; Critical values for Baseline

FBC, U&E, LFTs?

www.aids2014.org

RESULTS

www.aids2014.org

Baseline Patient Data on Enrollment

• 186 eligible patients, 50% females with 77% unemployment.

• At enrollment, median age was 33 years (Q1-Q3 26-

40), median weight 54 kg (Q1-Q3 47-60).

• HIV co-infection was 73% (median CD4 count 237,

Q1-Q3 121-399); 77% on ART. www.aids2014.org

Characteristic Overall Nurse Physician

Age (yrs),

Baseline Cohort Data

Median (Q1-Q3), n n=186 n=122 n=64

Sex, n (%)

Male

Female

Unemployed, n(%), n=173

93 (49.7)

94 (50.3)

133 (76.9)

65 (52.8)

58 (47.2)

91 (78.5)

28 (43.8)

36 (56.2)

42 (73.7)

BMI, Median (Q1-Q3), n 19.6 (16.4-

22.6), n=133

19.1 (16.4-

21.9), n=110

Normal ALT, n (%), n=158

Normal creat clearance, n

(%), n=128

HIV positive, n (%), n=185

CD4 count,

Median (Q1-Q3), n

On ART, n (%), n=138 www.aids2014.org

142

(89.9)

116

(90.6)

135 (73.0)

237

(121-399), n=120

106 (76.8)

95

(89.6)

84

(93.3)

92 (75.4)

233

(120-424), n=85

72 (76.6)

22.3

(15.9-26.1), n=23

47

(90.4)

32

(84.2)

43 (68.3)

241

(135-352), n=35

34 (77.3)

P-value*

0.732

0.281

0.565

0.109

0.950

0.180

0.301

0.324

0.950

Are Initial Intensive Phase Outcomes

Worsened by Task Sharing?

Characteristic

Outcome, n (%), n=186

MDR-TB diagnosis to Tx start

(days),

Median (Q1-Q3), n

Tx start to culture conversion

(days),

Median (Q1-Q3), n

Overall

71 (51-97),

186

Nurse

71 (51-96),

123

Physician

74.5 (51-98),

64

P-value*

0.810

58 (32-92),

149

57 (32-91),

101

62 (32-111.5),

48

0.594

Tx start to end of intensive phase (days),

Median (Q1-Q3), n

196 (180-

210) 143

196

(186-212)

98

196

(176-205)

45

0.608

*P-value from a Fisher’s exact test for categorical outcome, from a Wilcoxon rank-sum test for diagnosis to Tx start, and from a log-rank test for the time-to-event variables www.aids2014.org

Are Intensive Phase Outcomes

Worsened by Task Sharing?

www.aids2014.org

Are Negative Outcomes Increased?

• There was no significant difference between nurse managed patients and physician managed patients for time from treatment initiation to a negative outcome (default, failure or death) (p=0.561, HR=1.17)

Andersen, P.K., et al. 2012. Competing risks in epidemiology: possibilities and pitfalls; International Journal of

Journal of the American Statistical Association, 94(446), 496{509.

Are Final Treatment Outcomes

Worsened?

Nurse Physician P-value* Characteristic

Outcome, n (%), n=186

Overall

Still on Treatment (Tx) 68 (36.6)

Cure

Failure

Death

Default

Tx start to a negative outcome (default, failure or death) (days),

Median (Q1-Q3), n

51 (27.4)

12 (6.5)

26 (14.0)

29 (15.6)

134

(32-350)

61

*P-value from a log-rank test

47 (38.2)

35 (28.5)

6 (4.9)

18 (14.6)

17 (13.8)

134

(26-370)

39

21 (33.3)

16 (25.4)

6 (9.5)

8 (12.7)

12 (19.1)

167.5

(32-308)

22

0.609

0.561

www.aids2014.org

CONCLUSIONS & LESSONS

LEARNED

www.aids2014.org

Conclusions from Data

• MDR-TB IP quality indicators are similar among patients initiated in a task sharing model.

• No difference in risk for negative outcomes was noted based on provider type suggesting task sharing may be a human resource solution to improve access to care in MDR-TB/HIV co-infection.

www.aids2014.org

Implementation Science

Lessons Learned

• Task sharing = equivalent, although not ideal outcomes

• Increase # of new initiations per week

– 6 in baseline period to 18 in NI-MDR period

• CNP see’s all patients at triage

• Implementation of baseline physical exams and symptom screening on 100% of CNP patients

• Increase in community-based management

– Less than 10% in baseline period to 29% in NIT period www.aids2014.org

Nurses Stepping Up to Increase Access to

Care

Bed capacity

HCW availability excellence?

here?

What if the provider has been clinic or home?

Individual Resources

Taxi availability

Health status to care?

www.aids2014.org

Acknowledgements

• Medical Research Council

– Martie van der Walt

• Ugu District Department of

Health

– Ntombasekaya Mlandu

– Bheki Shazi

• National Department of

Health DR-TB Directorate

– Norbert Ndjeka

– Pamela Richards

– David Mamjeta

• Murchison & KGV Hospitals

– Simi Lachman & Iqbal Master

– Marge Govender-Singh

– BL Ngesi

• KwaZulu-Natal Department of Health

– Jackie Ngozo

– Bruce Margot

• Johns Hopkins University

– Louise Walshe & Jeane Davis

– Chakra Budhathoki

– Rachel Kidane, Keya Joshi, Katrina

Reisner, Maria Brown www.aids2014.org

Contact Details

• Jason Farley

– jfarley1@jhu.edu

– @jasonfarleyJHU www.aids2014.org

www.aids2014.org

Download